Advertising Disclaimer
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Möller, H. E.
Right arrow Articles by Ullrich, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Möller, H. E.
Right arrow Articles by Ullrich, K.
Related Collections
Right arrow Genetics & Dysmorphology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 6 December 2003, pp. 1580-1583

SUPPLEMENT ARTICLE

Brain Imaging and Proton Magnetic Resonance Spectroscopy in Patients With Phenylketonuria

Harald E. Möller, PhD*, Josef Weglage, MD{ddagger}, Ulrich Bick, MD§, Dirk Wiedermann, PhD||, Reinhold Feldmann, MD{ddagger}, Kurt Ullrich, MD

* Max Planck Institute of Cognitive Neuroscience, Leipzig, Germany
{ddagger} Department of Pediatrics, University of Münster, Münster, Germany
§ Department of Radiology, University of Chicago, Chicago, Illinois
|| Department of Pediatrics, University of Hamburg, Hamburg, Germany
Max Planck Institute of Neurological Research, Köln, Germany

Magnetic resonance imaging studies in patients with phenylketonuria (PKU) revealed white matter alterations that correlated to most recent blood phenylalanine (Phe) concentrations as well as to brain Phe concentrations measured by magnetic resonance spectroscopy. The clinical significance of these changes is unknown. Magnetic resonance imaging data thus have no impact on therapeutic recommendations for adolescents and adults with PKU. Kinetic investigations of patients by magnetic resonance spectroscopy showed differences in brain Phe concentrations despite similar blood Phe levels. These were influenced by interindividual variations of blood-brain barrier Phe transport constants and by variations of the individual brain Phe consumption rate. Blood-brain barrier Phe transport characteristics as well as brain Phe consumption rates thus seem to be causative factors for the individual outcome in PKU.

Key Words: phenylketonuria • brain imaging • proton magnetic resonance spectroscopy

Abbreviations: Phe, phenylalanine, PKU, phenylketonuria • MRI, magnetic resonance imaging • Kt, Michaelis-Menten transport constant • Tmax, maximal transport velocity • Vmet, consumption velocity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
A. V. Glushakov, O. Glushakova, M. Varshney, L. K. Bajpai, C. Sumners, P. J. Laipis, J. E. Embury, S. P. Baker, D. H. Otero, D. M. Dennis, et al.
Long-term changes in glutamatergic synaptic transmission in phenylketonuria
Brain, February 1, 2005; 128(2): 300 - 307.
[Abstract] [Full Text] [PDF]